
Buy Synthroid online for hypothyroidism: daily levothyroxine replaces the thyroid hormone that runs your energy, temperature, weight and digestion. The molecule is not a substitute for your own hormone. It is a copy of it, built in a factory rather than a gland, and it cannot restart the one you have. Absorption happens in a three-hour window that breakfast can close.
| Name | Strength | Starting Price |
|---|---|---|
| Synthroid (generic levothyroxine) | 25 mcg · 50 mcg · 75 mcg · 100 mcg · 125 mcg · 150 mcg · 200 mcg | From $0.11 per tablet |
What this page covers
Synthroid Is Levothyroxine Used for Hypothyroidism
Synthroid is the brand name for levothyroxine sodium. The molecule is a synthetic copy of thyroxine, written on laboratory reports as T4. A healthy thyroid releases it around the clock. Approved use is hypothyroidism of any origin. That covers failure in the gland itself, in the pituitary and in the hypothalamus. Suppressing TSH after surgery for thyroid cancer is the second approved use.
Replacement is the word that matters. Nothing in the tablet pushes the gland to work harder, and nothing repairs it. Most people arrive at a prescription through Hashimoto thyroiditis. That is an autoimmune condition, which means the immune system slowly damages the thyroid itself. Surgery to remove the gland accounts for much of the rest. So does radioiodine, a treatment that deliberately shuts an overactive thyroid down. Either way the tissue that made the hormone is gone or no longer working. The tablet takes over its job, which is why treatment is usually lifelong. Stopping brings symptoms back over weeks rather than days.
The hormone arrives in a form the body still has to finish. T4 is the storage version, and on its own it does almost nothing. Your liver, kidneys and muscles strip a single iodine atom from it. What remains is T3, the active form that cells actually respond to. Conversion runs gradually, hour by hour, rather than all at once. One tablet a day is therefore enough, because the body draws on that supply at its own pace.
Around 20 million Americans take a thyroid hormone. Levothyroxine sits among the four most dispensed medications in the country, at close to 80 million prescriptions a year. Familiarity has a downside. People buy Synthroid online, refill for a decade and never learn why the timing rules exist. Most avoidable problems start there. A diagnosis that is still open calls for a proper thyroid work-up rather than another refill.
When to Take Synthroid and Why the Jejunum Decides
The label asks for one daily tablet on an empty stomach. Half an hour to an hour before breakfast is the window. Between 40 and 80 percent of the tablet is absorbed. Published reviews narrow the usual range to 62 to 82 percent.
Absorption does not happen in the stomach. Acid dissolves the tablet. The hormone then crosses the lining of the jejunum and the upper ileum. Most of that occurs within the first three hours. Anything that binds levothyroxine in that stretch of bowel removes part of the dose. It never reaches the blood at all.
That single fact explains every rule that otherwise looks arbitrary. Four hours of separation is the standard interval for the products below, and the label names most of them by class. Chemistry in the lumen is the reason, not caution.
- Magnesium supplements, which people rarely think to mention
- Calcium carbonate and calcium citrate, including chewable antacids
- Iron salts, alone or inside a multivitamin
- Phosphate binders such as sevelamer and lanthanum carbonate
- Bile acid sequestrants including cholestyramine and colesevelam
- Sucralfate, aluminium and magnesium antacids, and orlistat
Acid-lowering treatment belongs in a separate category. Omeprazole and esomeprazole do not bind the hormone. They raise gastric pH instead, and a tablet that dissolves poorly delivers less. Requirements often creep upward after a proton pump inhibitor is added. The fix is a repeat TSH rather than an assumption.
One newer conflict deserves naming. Oral semaglutide has to be swallowed on an empty stomach with a small sip of water. Nothing else may follow for thirty minutes. Both tablets therefore claim the same morning window. Taken together, they raised total thyroxine exposure by 33 percent in the interaction study behind that label. Hours of separation and a follow-up thyroid panel are the usual answer.
How Long After Synthroid Can You Drink Coffee?
About an hour. The figure behind that answer is unusually clean. In a controlled study of espresso, coffee cut the average rise in serum T4 by 36 percent. That was in hypothyroid patients. Healthy volunteers lost 29 percent. Peak levels fell by 30 and 19 percent.
Waiting sixty minutes erased the effect entirely. Participants who took water first and coffee an hour later absorbed the hormone normally. Milk, soy beverages and high-fiber breakfasts behave the same way. Soy is the strongest of them after coffee itself.
Mornings do not suit everyone. Bedtime dosing is a recognized alternative, taken three to four hours after the last meal. Nothing has entered the stomach for hours by then, and breakfast stops being a problem. Consistency matters more than which hour you pick. The absorbed fraction shifts when the routine shifts.
Synthroid Dosage Starts With Your Body Weight
Full replacement is calculated at 1.6 mcg per kilogram of body weight. That figure suits an adult with no working thyroid tissue and no heart disease. Twelve tablet strengths exist so the arithmetic can be met closely. They run 25, 50, 75, 88, 100, 112, 125, 137, 150, 175, 200 and 300 mcg.
Full replacement dose by body weight
| Body weight | Calculated at 1.6 mcg per kg | Nearest tablet strength |
|---|---|---|
| 50 kg / 110 lb | 80 mcg | 75 or 88 mcg |
| 60 kg / 132 lb | 96 mcg | 100 mcg |
| 70 kg / 154 lb | 112 mcg | 112 mcg |
| 80 kg / 176 lb | 128 mcg | 125 or 137 mcg |
| 90 kg / 198 lb | 144 mcg | 150 mcg |
| 100 kg / 220 lb | 160 mcg | 150 or 175 mcg |
Calculated from the full replacement figure in the SYNTHROID label. Partial thyroid function lowers the requirement.
Two groups start well below the calculated figure. Older adults and anyone with coronary disease begin at 12.5 to 25 mcg. Restoring metabolic rate quickly increases the work the heart has to do. Angina is the reason for that caution.
Adjustments then move in those same 12.5 to 25 mcg steps. Four to six weeks separate them. Cardiac patients wait six to eight weeks between changes. Untreated adrenal insufficiency has to be corrected before any of this. Starting thyroid hormone first can precipitate an adrenal crisis.
Pregnancy changes the arithmetic immediately. Requirements rise, and often early. The label asks for TSH as soon as a pregnancy is confirmed. At least one test follows in every trimester. Straight after delivery the pre-pregnancy dose is resumed.
What Is Considered a High Dose of Synthroid?
There is no universal number. That is the honest answer and rarely the expected one. A 200 mcg tablet is ordinary for someone weighing 125 kg with no thyroid left. The same tablet in a 50 kg woman with partial gland function is more than double what she needs.
Weight sets the expectation. The laboratory settles it. At 1.6 mcg per kilogram, a 68 kg adult lands near 110 mcg. Anything far above that in a person of that size deserves an explanation. Suppressive treatment after thyroid cancer is the common one, and there the aim is deliberately to hold TSH below range.
Outside that setting, a dose is high when TSH sits under the reference range. The milligram count on the bottle does not decide it. Symptoms follow the same logic. A racing pulse at 75 mcg matters more than a calm one at 175 mcg.
Buy Synthroid Online Without Insurance
Levothyroxine is prescription-only in the United States. Anyone planning to buy Synthroid online needs a valid prescription first. What changes dramatically after that is price. The cost of Synthroid depends less on the pharmacy than on which version is dispensed. That gap is wider than in almost any other common medication.
Two kinds of published figures are worth separating. The first is the federal acquisition benchmark, which records what pharmacies actually pay. Retail is the second, and it is what an uninsured person is charged. Both appear below at 75 mcg, the strength most often quoted in price surveys.
Synthroid and generic levothyroxine at 75 mcg
| What is being priced | 30 tablets | 90 tablets |
|---|---|---|
| What a pharmacy pays for the tablets | ||
| Generic levothyroxine at 4.6 cents a tablet | $1.39 | $4.17 |
| Brand Synthroid at $1.66 a tablet | $49.87 | $149.60 |
| What a person without insurance is charged | ||
| Generic at average retail | about $24 | about $71 |
| Generic with a free discount card | from $9.90 | $10.00 at Walmart |
| Brand at average retail | about $71 | $213.73 |
| Brand through the manufacturer program | $39.95 | $99.90 |
Acquisition figures from the federal pharmacy pricing benchmark, effective August 2026. Retail and card figures from published pharmacy price comparisons. Where only a 90-tablet retail price is published, the 30-tablet column shows a third of it.
Counting a supply is simple here. Ninety-day quantities are where the savings sit, since the dispensing fee is charged once instead of three times. Dose changes are rare once things settle, so the larger quantity is usually safe to order.
A caution applies to people who buy Synthroid online from sites promising no prescription. Levothyroxine has a narrow therapeutic index. Small differences in tablet content produce real clinical effects. Unverified supply chains are where subpotent tablets circulate.
Coupons Copay Cards and Synthroid Home Delivery
Three separate savings routes exist for the brand. They do not stack. The monthly figure changes by a factor of four or more depending on which one fits you.
A mail-order route runs under the name Synthroid Delivers. One dispensing pharmacy fulfils it, and the pricing targets people paying cash. Published prices are $39.95 for 30 days and $99.90 for 90. Both undercut brand retail by a wide margin. Delivery goes to the home, and the prescription transfers once rather than being refilled locally.
Commercial insurance opens a different door. A copay card can bring the monthly share down to around $25. It works at an ordinary pharmacy counter. Government coverage is excluded from these cards as a rule. Anyone on Medicare or Medicaid falls back on plan pricing or on the generic.
Free pharmacy discount cards are the third route and the broadest. They work best on generic levothyroxine. Ninety tablets land near $10 at large chains. Discount cards list a Synthroid coupon 90-day option beside the monthly one. Prices differ by chain in ways that look random. The same generic quantity has been published at $10.00 and at $22.17 on the same day.
One habit undermines all three. Chasing the lowest monthly price means changing manufacturers repeatedly, which costs something on this particular hormone.
Synthroid Generic and Why Price Varies by Strength
Price is the one place where the brand and its copies genuinely part company. Before the numbers, the question that brings most people to this comparison deserves a straight answer.
Is Synthroid the Same as Levothyroxine?
Yes, in the way that matters most. Both carry levothyroxine sodium at the same twelve strengths. The two also meet the same federal bioequivalence standard, and generics hold an AB rating for interchangeability. Substitution at the counter is legal and routine because of that rating.
Differences sit around the molecule rather than in it. Fillers, colorants, tablet appearance and the manufacturer behind the bottle all vary. Synthroid has run under one maker with one formulation for seven decades. A change from one generic maker to another usually passes without any notice at the counter.
One detail gives the question practical weight. Levothyroxine is dosed in micrograms, so a small shift in what a tablet delivers can move a laboratory result. Avoiding generics is not the answer. Staying with whichever product you started on is.
Synthroid price behaves in a way most people never notice. Across all twelve strengths the brand costs the same. The spread is under half of one percent, from 25 mcg to 300 mcg. Generic pricing does the opposite. It tracks the hormone, spreading almost threefold from the lowest strength to the highest.
What Synthroid costs by strength
| Strength | 30 tablets | 90 tablets |
|---|---|---|
| 25 mcg | $49.78 | $149.34 |
| 50 mcg | $49.87 | $149.60 |
| 75 mcg | $49.87 | $149.60 |
| 100 mcg | $49.87 | $149.62 |
| 125 mcg | $49.87 | $149.62 |
| 150 mcg | $49.89 | $149.68 |
| 200 mcg | $49.73 | $149.20 |
Prices from NADAC, the federal acquisition benchmark published by CMS, effective August 2026. One tablet a day makes 30 tablets a month and 90 a quarter. The seven strengths stocked most widely are shown and the other five sit inside the same pattern. These are pharmacy costs and not counter prices.
That flat line has a practical side. Titration moves people between strengths for months at a time, and none of those moves changes what the brand costs. A dose that settles at 137 mcg is billed the same as one that settles at 75 mcg.
Generic pricing carries a quirk of its own. In-between strengths cost more than the round ones above them, so a month of 137 mcg runs 5.1 percent above a month of 150 mcg. At 112 mcg the premium over 125 mcg is 3.3 percent. Those three strengths exist because titration needs the gaps filled.
Benchmark figures show what a pharmacy pays rather than what a patient pays, and the distinction matters more here than anywhere else on this page. A copay card puts the brand near $25 a month, and the manufacturer program puts it at $39.95 without insurance. What that buys is one factory and one formulation for as long as the prescription runs, with no substitution to notice at a refill. Generic tablets meet the same federal standard and cost a fraction of it, which is why they fill the overwhelming majority of prescriptions. Both things are true at once.
How Synthroid Compares With Tirosint and Unithroid
Synthroid is not the only branded levothyroxine on the American market. Levoxyl, Unithroid, Euthyrox, Levo-T and Tirosint all deliver the same hormone. Prescriptions move between them more often than patients realise. Everything except the active ingredient separates them.
Fillers are the practical difference. Tablets typically contain lactose, colorants and binders such as acacia. A minority of people react to those rather than to the hormone. Tirosint is a soft gel capsule. It holds levothyroxine, gelatin, glycerin and water, with no lactose and no dyes. Tirosint-SOL is the same idea as a liquid. Both were designed for people whose absorption is unreliable, which links them to the intestinal causes described further down.
Cost separates them too, and not in the expected direction. The most expensive levothyroxine at the benchmark is not the best known one, and being branded says nothing consistent about price.
Levothyroxine brands side by side
| Brand | Form | A month at the benchmark |
|---|---|---|
| Synthroid | Tablet | About $50 at every strength |
| Levoxyl | Tablet | $23 to $42 |
| Unithroid | Tablet | $125 to $127 |
| Euthyrox | Tablet | Not carried in the benchmark |
| Tirosint | Soft gel capsule | Not carried in the benchmark |
| Tirosint-SOL | Oral solution | Not carried in the benchmark |
Thirty tablets at the same federal benchmark, effective August 2026. Ranges cover the difference between the lowest and the highest strength. These are pharmacy acquisition costs and they do not predict what any counter charges.
Desiccated thyroid extract belongs to a different category. Armour Thyroid and NP Thyroid are made from porcine glands. They contain both T4 and T3 in a ratio that varies with the raw material. Neither has ever held FDA approval. Regulators signalled in August 2025 that this would be addressed. March 2026 brought softer language and a risk-based approach. Draft guidance on compliance priorities was promised by August 2026. That guidance had not appeared as this page was written, and roughly 1.5 million Americans hold prescriptions meanwhile.
Synthroid Side Effects That Mean Too Much T4
Most of what appears on a side effect list here is not a reaction to the molecule. It describes having too much thyroid hormone in circulation. That is a dosing question rather than a tolerance question. The distinction matters. An adjustment answers it, not a switch.
- A resting pulse that has climbed, or palpitations noticed at night
- Fine tremor in the hands and new heat intolerance
- Broken sleep and a wired anxious feeling that is new
- Looser or more frequent stools after years of the opposite
- Weight coming off without any change in eating
Two consequences of long-term excess are quiet enough to miss. Both hold their own place in the label. Older adults carry a raised risk of atrial fibrillation when TSH stays suppressed. Bone mineral density falls under sustained over-replacement. Postmenopausal women with thinning bone carry most of that risk.
Hair shedding sits in a category of its own. It causes a great deal of unnecessary alarm. Shedding typically starts within the first months of treatment. The whole scalp thins rather than patches. Settling follows as thyroid status stabilises. Untreated hypothyroidism causes exactly the same pattern, so the tablet is often blamed for something it is correcting.
Genuine reactions to the tablet itself do occur. They look different. Rash, itching or swelling points at the fillers rather than the hormone. Changing to a lactose-free or dye-free formulation resolves most of these.
Why Synthroid Is Not a Weight Loss Medication
This medication carries exactly one boxed warning. It concerns neither the heart nor the bones. Thyroid hormones must not be used for obesity or for weight reduction. Doses beyond normal hormonal requirements produce serious and potentially life-threatening toxicity. That warning exists because the practice existed.
Restoring a normal thyroid state does help with the weight hypothyroidism added. Much of that gain is fluid and glycogen rather than fat. It comes off over the first months and then stops. Appetite often rises as metabolism normalises, which surprises people expecting the opposite.
Pushing the dose higher to force more is where trouble starts. Extra hormone burns lean tissue alongside fat. Atrial fibrillation and bone loss both track cumulative excess rather than a single high reading. Neither announces itself early.
Weight that will not shift while TSH sits in range says something useful. The thyroid is not the obstacle. Insulin resistance, low iron, low vitamin D and sleep apnea produce the same plateau. Medication effects do too. All of them respond to metabolic assessment rather than to a larger tablet.
Gut Conditions That Push a Levothyroxine Dose Higher
Some people climb through three or four dose increases and still hand in a high TSH. Investigated properly, the explanation often sits in the digestive tract. A published series of apparently refractory patients found gastritis in 24 percent. Helicobacter pylori infection accounted for 18 percent. Interference from other medications explained 15.6 percent.
Coeliac disease accounted for 2.5 percent and previous bariatric surgery for 1.2 percent. Missed doses explained 10 percent. Each of these damages or bypasses the stretch of intestine that absorbs the hormone. Treating the underlying condition can cut the requirement substantially. Eradicating H. pylori has reduced requirements by up to a third in reported series.
- Coeliac disease, which damages the jejunal lining directly
- Atrophic gastritis and H. pylori, through loss of gastric acid
- Lactose intolerance, where the tablet filler is the problem
- Inflammatory bowel disease affecting the small intestine
- Gastric bypass and sleeve procedures, which alter the surface available
- Gastroparesis, a documented cause of persistently raised TSH
Traffic runs in both directions between the thyroid and the bowel. Low thyroid hormone slows intestinal transit. Constipation is often an early symptom, and it eases after replacement starts. Bacterial overgrowth of the small intestine is more common in autoimmune thyroiditis than in controls.
Microbial metabolism enters the picture as well. Bacterial beta-glucuronidase and sulfatase deconjugate thyroid hormone. That returns it to the enterohepatic circulation. Short-chain fatty acids and secondary bile acids influence deiodinase activity in the liver. Those are the same enzymes that convert T4 into T3. Absorption of iodine, selenium, iron and zinc depends on the same ecosystem.
A dose that keeps climbing is a reason to look at the gut properly. Adding another 25 mcg answers nothing. Where malabsorption is suspected but unproven, a supervised absorption test separates it from missed doses. The two produce an identical laboratory picture and completely different solutions.
TSH Is the Only Feedback a Synthroid Dose Gets
Nothing about how you feel in the first fortnight tells you a dose is correct. Levothyroxine has a half-life of six to seven days. It stretches to nine or ten days when someone is hypothyroid. A new dose therefore needs roughly six weeks to reach a steady level. Checking TSH earlier produces a number that is still moving.
Six to eight weeks after any change is the interval the label specifies. Once a dose is settled, testing drops to every six to twelve months. Any of the situations above resets that clock. Pregnancy, a new proton pump inhibitor, a bowel diagnosis or a change of manufacturer all qualify.
Getting this wrong is common rather than exotic. A retrospective analysis published in January 2026 found abnormal TSH in 56.2 percent of treated adults. Among those reading low, one in ten also had a raised free T4. Such numbers do not describe rare mismanagement.
For one group of people the dose has a second audience. Many who take levothyroxine arrived at it through treatment for Graves’ disease, where radioiodine or surgery leaves the thyroid underactive on purpose. Graves’ also produces an eye disease of its own, and that does not end when the thyroid is dealt with. The 2021 European guidelines list thyroid dysfunction among its modifiable risk factors, next to smoking and high cholesterol. Dysfunction there means both directions. Too little replacement and too much each work against the orbit.
That changes what a delayed retest costs. For most people a TSH drifting for a few months is an inconvenience. For someone with an active orbitopathy it is a risk factor left running. Bulging, double vision, a gritty ache behind the eye or lids that no longer close fully are worth reporting rather than waiting out. They belong with somebody who examines the orbit rather than with the next thyroid panel.
TSH answers one question and not every question. Free T4 adds information when the pituitary itself is the problem. Symptoms that persist at a comfortably normal TSH deserve a look elsewhere rather than a larger tablet. Iron studies, vitamin D and sleep are the usual candidates.
One laboratory trap is worth knowing before the next blood draw. Biotin at 10 mg or more interferes with thyroid immunoassays. TSH reads falsely low while free T4 and T3 read falsely high. Such a pattern imitates over-replacement precisely. Hair and nail supplements are exactly where high-dose biotin hides. Stopping it for a few days before testing removes the interference.
Metformin creates a smaller version of the same confusion. It lowers TSH in people taking levothyroxine. The result can look like an overdose that is not there. Whichever explanation applies, a repeat test comes before a dose cut.
What the 2026 Levothyroxine Recall Actually Covered
Searches for a Synthroid recall rose sharply in 2026. The answer contains an important correction. Brand Synthroid was not recalled. Three recalls were issued for generic levothyroxine tablets. Every one of them was for subpotency, meaning the tablets held less hormone than the label stated.
Macleods Pharma USA began the first in February 2026. It covered 150 mcg tablets across 1,315 bottles. Accord Healthcare followed in June with 6,432 bottles of the 300 mcg strength. Major Pharmaceuticals initiated the largest in July. That one spanned twelve listed configurations from 25 mcg to 150 mcg. All three carry Class II designation in the federal enforcement record.
None of this was new in 2026. The previous year carried a dozen subpotent listings from a single manufacturer, and another firm added one more. Two further recalls in that period failed in other directions: tablets that came out super-potent, and a batch pulled for a foreign substance. Content that does not match the label is a recurring problem in this category rather than one accident.
Class II has a specific meaning in that record. It marks a product that may cause temporary or reversible harm, with serious injury unlikely. For a hormone taken every day, the practical effect of subpotent tablets is a slow return of hypothyroid symptoms rather than an acute event.
A recall is not a shortage. The two are constantly confused online. Levothyroxine does not appear in the federal shortage database at all. Affected lots are identified by number on the bottle label. Pages advertising a levothyroxine shortage in 2026 describe something that does not exist.
Practical consequences follow from the narrow therapeutic index. Symptoms returning while the dose has not changed are worth taking seriously. Fatigue and cold intolerance creeping back after a new bottle fit that picture. Checking the manufacturer name and lot number on the label takes seconds.
Staying with one manufacturer is the sensible default for this hormone. Whether that manufacturer makes the brand or a generic matters less. At the pharmacy counter a switch is often unavoidable. Where it happens, a TSH six weeks later confirms nothing has shifted. Anyone who plans to buy Synthroid online should expect the same discipline: the same product each time, and one blood test after any change of source.
Medical Disclaimer
This page is educational and does not replace individual medical care. Synthroid requires a prescription. The correct dose depends on body weight, remaining thyroid function, age, heart health, pregnancy status and the other medications and supplements you take. Talk to your physician before starting, changing or stopping any treatment described here.